SCHEMBL6319094

SCHEMBL6319094

O=C1C2CN(C(=O)OCc3ccccc3)C(c3ccccc3)C2C(=O)N1Cc1ccccc1

nearest known ligand 0.45

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.45
CYP2D6 P10635 1/20 0.45
TSHR P16473 2/20 0.43
SMN1; SMN2 Q16637 1/20 0.43
PSEN1 P49768 1/20 0.43
PSEN2 P49810 1/20 0.43
APH1B Q8WW43 1/20 0.43
NCSTN Q92542 1/20 0.43
APH1A Q96BI3 1/20 0.43
PSENEN Q9NZ42 1/20 0.43
MEN1 O00255 2/20 0.43
KMT2A Q03164 2/20 0.43
CYP2C9 P11712 2/20 0.42
CYP3A4 P08684 1/20 0.42
HTR2C P28335 1/20 0.42
CTRB1 P17538 1/20 0.42
MAPK1 P28482 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6309596 0.86 CACNA1G (0.43) ALDH1A1CYP2D6MEN1KMT2AHTR2C
SCHEMBL5744862 0.81 CYP2D6 (0.41) ALDH1A1CYP2D6TSHRCYP2C9CYP3A4
SCHEMBL6311540 0.76 CCR5 (0.46) SMN1; SMN2PSEN1PSEN2APH1BNCSTN
SCHEMBL6316974 0.72 GRIN2B (0.47) SMN1; SMN2PSEN1PSEN2APH1BNCSTN
SCHEMBL5963519 0.71 PSEN1 (0.45) SMN1; SMN2PSEN1PSEN2APH1BNCSTN
SCHEMBL19251183 0.70 HTR2C (0.52) SMN1; SMN2PSEN1PSEN2APH1BNCSTN
SCHEMBL14762185 0.70 AGTR2 (0.50) SMN1; SMN2PSEN1PSEN2APH1BNCSTN
SCHEMBL5869413 0.69 F2 (0.47) SMN1; SMN2PSEN1PSEN2APH1BNCSTN
SCHEMBL1820197 0.69 F2 (0.47) SMN1; SMN2PSEN1PSEN2APH1BNCSTN
SCHEMBL5517077 0.69 HTR2C (0.64) ALDH1A1SMN1; SMN2PSEN1PSEN2APH1B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050043354-A1 NK1 antagonist PFIZER INC 2005-02-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050043354-A1 NK1 antagonist TACR2, TACR1, TAC3 ALDH1A1 2855/4885CYP2D6 2419/4885TSHR 975/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.